NBP is NovaBridge Biosciences (Healthcare) — a non-dividend-paying stock. Trading at $1.80. Market cap: $208M.
Stock snapshot
| Price | $1.80 |
| Market cap | $208M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
About NBP
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
Related non-dividend companies
Other non-dividend stocks investors research alongside NBP. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is NBP's current stock price?
NBP (NovaBridge Biosciences) is currently trading at $1.80.
Does NBP pay a dividend?
NBP (NovaBridge Biosciences) does not currently pay a regular dividend.
Track NBP in DiviDrip
Add NBP to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search NBP and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.